Sanara MedTech Inc.

We are a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. Our products are designed to achieve our goal of providing better clinical outcomes at a lower overall cost for healthcare systems. We strive to be one of the most innovative and comprehensive providers of effective surgical solutions and are continually seeking to expand our offerings for patients requiring surgical treatments in the United States. We primarily market and sell soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Our soft tissue repair products include, among other products, our lead product, CellerateRX Surgical Powder ( CellerateRX Surgical ), a hydrolyzed collagen that aids in the management of surgical wounds, and BIASURGE Advanced Surgical Solution ( BIASURGE ), a sterile no-rinse, advanced surgical solution used for wound irrigation. Our bone fusion products include, among other products, BiFORM Bioactive Moldable Matrix ( BiFORM ), an osteoconductive, bioactive, porous implant that allows for bony ingrowth across the graft site, and ALLOCYTE Plus Advanced Viable Bone Matrix ( ALLOCYTE Plus ), a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers. We also utilize an in-house research and development team, Rochal Technologies.